"Do not fear," he said. "We will not go quietly into the night. We will defend our home, and we will drive this Shadow Entity back."
The development of IPX-822 is an ongoing process, with future plans to: IPX-822
Several clinical trials have evaluated the safety and efficacy of IPX-822: "Do not fear," he said